Ensysce Biosciences (ENSC) Market Capitalization (2018 - 2025)

Ensysce Biosciences (ENSC) has reported Market Capitalization for 8 consecutive years, with $2.4 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Market Capitalization fell 58.57% year-over-year to $2.4 million in Q4 2025; TTM through Dec 2025 was $2.4 million, a 58.57% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 58.57% from the prior year.
• Market Capitalization was $2.4 million for Q4 2025 at Ensysce Biosciences, down from $7.5 million in the prior quarter.
• Over five years, Market Capitalization peaked at $232.6 million in Q2 2021 and troughed at $1.6 million in Q4 2022.
• A 5-year average of $30.5 million and a median of $5.2 million in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization plunged 98.29% in 2022 and soared 217.6% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $94.8 million in 2021, then sank by 98.29% to $1.6 million in 2022, then jumped by 48.2% to $2.4 million in 2023, then soared by 136.63% to $5.7 million in 2024, then tumbled by 58.57% to $2.4 million in 2025.
• The last three Market Capitalization figures came in at $2.4 million (Q4 2025), $7.5 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.